Goldman Sachs Group Operating Cash Flow decreased by 95.8% to -$31.87B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.4%, from -$37.23B to -$31.87B. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.47B | -$39.26B | $30.27B | -$19.53B | $45.39B | $16.01B | $9.40B | $31.90B | -$25.53B | -$28.36B | -$28.04B | -$38.06B | -$37.23B | -$16.28B | -$31.87B |
| QoQ Change | — | -291.8% | +177.1% | -164.5% | +332.4% | -64.7% | -41.3% | +239.2% | -180.0% | -11.1% | +1.1% | -35.7% | +2.2% | +56.3% | -95.8% |
| YoY Change | — | — | — | — | +121.8% | +140.8% | +148.1% | -29.7% | -259.5% | — | -398.1% | -49.1% | -32.8% | — | +14.4% |